Upcoming Webinars Archived Webinars Training Vitals Host A Webinar About Get Updates Contact

FDA Approves VivaLnk’s Wearable Device for Continuous Temperature Monitoring

XTALKS VITALS NEWS

The soft and flexible wearable device uses the company’s eSkin technology to collect temperature readings and display them on a connected smartphone or tablet.

Share this!

April 6, 2017 | by Sarah Hand, M.Sc.

Digital health startup, VivaLnk, has just received FDA clearance for their continuous temperature monitoring medical device, Fever Scout. The soft and flexible wearable device uses the company’s eSkin technology to collect temperature readings and display them on a connected smartphone or tablet.

According to VivaLnk, the device is ideal for remote monitoring of a child’s fever. The wearable device will be available for purchase by consumers at stores like Best Buy, Target and Amazon.

“Driving meaningful innovation to help improve people's health and wellbeing is a part of our DNA at VivaLnk. We developed Fever Scout to help take the guesswork out of monitoring and keeping track of a patient's fever,” said Jiang Li, co-founder and CEO of VivaLnk. “Starting today, consumers can now own a wearable thermometer that is an accurate medical grade device, child-friendly and does its job while the patient is sleeping.”



Fever Scout uses Bluetooth to connect to the product’s app on a smartphone or tablet device. The thermometer patch itself can be stuck to the skin using a medical-grade adhesive, and patients can wear the device for up to seven days before the battery will need to be recharged.

The medical device continuously monitors a patient’s temperature and sends alerts to the app whenever the patient’s fever increases. Fever data collected over time can be submitted to a patient’s doctor along with other symptoms and medication schedules, to provide an overall picture of whether the person’s health is improving.

“It's no secret in the medical community that the trouble with consumer wearables is that they are not medical grade devices, and have lacked the accuracy and consistency required for patient care,” said Dr. Vernon Smith, Mayo Clinic-trained emergency physician from Avera Medical Group. “The introduction of Fever Scout signals a future where we can one day accurately use wearables to remotely monitor at-risk patients, like the elderly, by tracking baseline temperatures and anticipating when trouble might arise.”

While the design of the Fever Scout is certainly kid-friendly, its use can benefit patients and caregivers of any age. Patients recovering from surgery or cancer treatment and seniors who live with their primary caregivers could also use the Fever Scout for continuous body temperature monitoring.


Keywords:  FDA, Wearable Device, Remote Patient Monitoring


| NEXT ARTICLE | MORE NEWS | BLOGS | VIDEOS | POLLS & QUIZZES | WEBINARS |

Share this with your colleagues!

MORE NEWS
Samsung Bioepis and Takeda to Co-Develop Novel Biologic Drugs

August 22, 2017 - Biosimilars drugmaker Samsung Bioepis has joined forces with Takeda Pharmaceutical to develop biologic therapies in novel disease areas.

Featured In: Biotech News


Improving Administration of Blood Thinner Drugs through an Online Course for Nurses

August 22, 2017 - Patients’ refusal of blood thinners can influence a nurse’s decision to administer the drugs, but an online educational program could help to address this issue.

Featured In: Life Science News


Exploring the FDA’s Accelerated Approval Pathway

August 21, 2017 - Investigational new drugs that could fill an unmet medical need are sometimes granted “Accelerated Approval” by the US Food and Drug Administration (FDA) in an effort to make these medicines available to the patients who need them.

Featured In: Pharmaceutical News


LEAVE A COMMENT
 
  
THE XTALKS VITALS INDUSTRY BLOG

One Patient’s Perspective on Clinical Trials

REGISTER FOR THESE WEBINARS

Planning and Conducting Trials of the Latest Immunotherapies


ISO 13485:2016 for Medical Device Manufacturers: Ensuring a Smooth Transition through Effective Preparation


Medical Devices: Reviewing Regulatory Changes in the US and EU


Moving Beyond Regulatory and Performance Metrics in Starting Clinical Trials


Copyright © 2016-2017 Honeycomb Worldwide Inc.